Any news from Dr. Harold Katcher's E5 compound?

Harold made a very interesting comment on Josh Mitteldorf’s blog recently on aging in plants and exosomes:

Hi Josh et al.,
So there were various issues raised, two stand out, whether or not plants age, and 2. How can it be that fungi in the wild are immortal while those grown in the lab have a short lifespan.
So, as to whether plants age, you divided plant aging into three categories, annuals (why not biennials?) – horizontally spreading and vertically spreading plants, though I don’t know why you chose those categories – but the lifespans of those species named seem to illustrate the two modes of aging you propose, programmed aging and immortality. Annuals and biennials are semelparous, the develop to the point of sexual maturity, produce seeds and die. They respond to an environment (the coming of winter) they cannot survive, so in order for the species to persist, they must use their resources to advance themselves (annuals are the first to colonize virgin ground) and to load their genomes into seeds that can survive the winter. I believe, as in mammals, the cessation of growth, or the gaining of sexual maturity stops growth and leads to death (which would occur anyway). When the flowers are cut, they regrow multiple times, while without cutting, those same flowers would only appear once and die is easily explained by this paradigm, the dying (or better, fertilized, flower) sends a signal that stops flowering (a phytohormone?) , telling the plant it’s reached its goal of reproducing, and not to bother further. Cutting leaves the plant feeling unfulfilled and proffers its flowers for its next attempt at love. As for the vertical and horizontal, there are some apparently immortal tall trees, like sequoias, but as you say, short ones, like Joshua pines as well that appear immortal. What about all those spreaders, like grass, is it immortal. I asked Chat, which said, leaves are mortal, they live for days or weeks, whither and die. The grass persists as its meristems lie close to the ground and apart from reproducing sexually (wheat, rye, corn, rice, etc. are all grass seeds), it reproduces by rhizomes, runners, roots. So, it’s really hard to say if its immortal or not. But clearly “immortality” (non-aging) is possible for the plant kingdom, as is programmed development. As with animals, like the shark, it may be the case that continual growth simply makes the organism prey to natural causes of death. (It’s said that as the shark grows, as surface area grows by the square of the size, while mass by the cube, until the gills no longer have the surface area to provide enough oxygen to the body.
As to the immortality of wild fungi, I think the answer is to be found in your observations that the same fungi immortal in the wild, are very mortal in the laboratory. The first thing that crossed my mind was that there was something missing in laboratory conditions that was present in the wild. So, what was missing was the connection with plants. We know that beneath the forest floor lies a complex network of fungal mycelia, and that those fungal hyphae penetrate plant cells providing an intimate connect between the cytoplasm of the fungus and the cytoplasm of the plant cells.
Now, as some of you know, I’ve long held the belief that exosomes are one secret to immortality. Anyone who knows the literature would agree that exosome can have healing properties, in fact, anything that can be done with stem cells can be better done with exosomes. So, let’s imagine, as most do, that aging is caused by accumulated damage (it’s not – exactly) and that vertically and horizontally spreading plants are immortal. Then let us suppose that they never stop growing and therefore must be continually providing repair exosomes for their tissues. Now, the intimate connection between fungus and plant allows the fungus access to the plant repair exosomes, which it uses to repair its own damage. I’ve already shown that pig exosomes can be used to promote rejuvenation in rats (and also increased longevity, though with a small sample size) – and so the homology of exosomes may go back past the division of the higher Eukaryota from Protista, so that perhaps tree exosomes might help us as well? Anyway, that’s my take on your interesting essay.

From https://scienceblog.com/joshmitteldorf/2026/02/16/aging-in-plants-or-no-aging-in-plants/#comments

5 Likes

Latest update on the new experiment:

This newsletter is different from previous ones. It includes a lot of technical content to explain the results we’ve obtained so far and how the experiment will proceed. The scientific articles published by Katcher weren’t particularly clear or complete (something we only realized once we put them into practice), and so this first phase of the experiment we’ve conducted so far has helped us make the experiment much more robust.

When we began replicating Katcher’s seminal experiment based on his 2023 article published in the journal Geroscience, we realized that the article referred to the entire content of exosomes from the plasma of young pigs as the rejuvenating component, defined as extracellular vesicles ranging in size from 30 to 150 nanometers. However, upon analyzing another article by Katcher published in the journal Aging Cell in 2024, it becomes clear that the rejuvenating component is not described as the entire content of the exosomes, but as a specific and relatively small portion of that content. It is important to note that, in the composition described in the Geroscience article, Katcher also described the inclusion of extracellular vesicles larger than exosomes. Thus, there were two possible compositions to be tested. The first composition we produced was based on the first article, published in Geroscience in 2023.

The results of testing this first composition on old rats showed that it did not rejuvenate the animals. We performed a grip strength test before the injections and two grip strength tests after the injections. If rejuvenation had occurred and we had replicated Katcher’s results, grip strength would have been considerably higher 15 days after the end of the treatment injections. However, there was no significant difference at that point between the animals in the control group and the treated group. Below you can see the results of the three grip strength tests. The increase in grip strength in both the control and treated rats after treatment administration was likely due to a training effect in the animals (they were more accustomed to performing the test).


Average change in grip strength, expressed as a percentage. Control animals are shown in blue, and treated animals in red. The star indicates when the treatment was administered.

In addition, weight loss was approximately the same in the control group and the treated group, as can be seen in the graphs of the four weight measurements below.


Average change in weight, expressed as a percentage. Control animals are shown in blue, and treated animals in red. The star indicates when the treatment was administered.

We also collected blood samples from the rats before and approximately one month after treatment. We will have the results of these blood tests once the entire experiment is complete. However, based on the grip strength and weight measurements, it was clear that Katcher’s results were not being replicated. Since the rats were (and are) already very old and frail, we decided not to conduct the memory test (which takes 9 consecutive days, and for which the rats need to be transferred to another facility), also because, in Katcher’s experiment, the first memory test showed a relatively small improvement, since, apparently, memory is one of the last things to improve during rejuvenation.

In conclusion, in this first part of the experiment, we were able to test a total exosome composition (based on the 2023 article in Geroscience), and the result was that it did not cause acute rejuvenation as reported in Katcher’s experiment.

Second composition will be tested in early November

We are now preparing to test the second composition (the one based on the 2024 Aging Cell article). Last week, we went to the farm to collect pig blood to begin preparing this composition. The problem is that, since this new composition uses only a small fraction of the total range of exosomes, a larger amount of pig blood is needed to produce it. In addition, the time required to collect the appropriate fractions on the chromatographic column is longer. We also cannot use the same rats to test this new composition, as they are already too frail and old. Therefore, for the new composition, we will use a new group of old rats that will only be at the right age for treatment in early November, about six months from now. In any case, we would need several months to prepare the new composition, also because, in early November, we will inject the composition not only into old rats, but also into young rats.

In the first treatment, using the first composition, we used rats with an average age of 21 months; there were 10 rats in the treated group and 10 in the control group. However, the animals began to die very early, in both the treated and control groups, and so we are certain that, after 5 months — which is the planned duration of the entire experiment — even if the treatment were successful, we would have far fewer than 10 animals in the control group, which would compromise the statistics. Therefore, for this new composition, we will use “younger” old animals, approximately 12 months old. This way, we will be able to complete the full 5 months of the experiment, including the two doses (spaced 3 months apart), and we will be relatively certain that, 5 months later, we will still have 10 rats in the control group, or close to that number.

Survival curve for rats

By the way, this was a very important finding we made while conducting this first part of the experiment: it is extremely difficult to conduct the 5-month experiment (including two doses separated by 3 months, grip strength tests, memory tests, blood markers, and epigenetic tests) if we start the experiment after the Sprague Dawley rats are already over 20 months old. In the Geroscience article, the initial age of the old rats was not described precisely, but is indicated in the text as being between 18 and 24 months and in the graphs as being around 25 months. In the Aging Cell article, the initial age of the old rats is described as being 24 months.

However, based on the survival curve we obtained from the rats we initially had (shown below), we concluded that, in order to conduct the entire 5-month experiment and complete it with 10 animals (or so) per group, we would need to start the experiment when the middle-aged/old rats are 12 months old, ending it when they are 17 months old — certainly already old. Therefore, when we inject the new composition in early November, we will begin the experiment with the old rats with the animals being 12 months old. The young animals will be about 7 months old in early November. In the graph below, which corresponds to our rat survival curve, you can see that by the age at which we injected the first composition (20 months of age for one group of rats and 22.5 months of age for the other), about 50% of the 42 rats we initially had had already died.


Survival curve showing the percentage of live animals versus their age in months. Animals born on May 15, 2024, are shown in blue, and those born on July 31, 2024, are shown in red. The star indicates when the treatment was administered.

In summary, in early November (six months from now), we will test a specific exosome composition (based on the 2024 paper in Aging Cell) rather than a composition containing all exosomes. The difference between the two compositions is significant, so we believe the final outcome of the experiment remains quite uncertain. Over the next six months, we will need to produce the new composition in sufficient quantities for two doses for 10 old rats and 10 young rats, which will likely be a challenge, given that the amount of pig blood required and the processing time will be greater than for the first composition. Incidentally, the discovery that the second composition takes longer to produce than the first may partly explain why Katcher so frequently mentions in his interviews the difficulty of producing the rejuvenating compound in the quantity needed to rejuvenate a human or large animals. Apparently, this small fraction of the exosome pool takes a long time to isolate, and that is what we will discover and share with you in this new phase of the experiment, at the end of which we hope to have rejuvenated rats. The fight continues!

3 Likes

Why can’t they just call Harold and clear it up? Much easier. Great job though anyway.

1 Like

The point is replication. Are you saying they’ve never been in contact with Harold? That is odd.

1 Like

Hi, I’m Nicolás Cherñavsky, president of the ICR, which is reproducing Katcher’s study. Harold’s relationship with a company impedes him of helping us, so we can’t just call Harold and clear it up. That kind of problem arises from the investment system, and that’s why we created a non-profit for carrying out the experiment with the funding coming from donations, in order we can say publicly what we are doing and the results.

7 Likes

Hi, I just gave an answer to Biceps that probably could be given to you too.

3 Likes

Amazing work Nicolás! Thank you for being so transparent of the process

1 Like

In July of this year (2026), we will conduct a mouse rejuvenation experiment using the new composition, prepared by following the scientific article published by Harold Katcher in 2024 in the journal Aging Cell. In other words, we won’t have to wait until November of this year (2026) — when we will begin testing the new composition on rats — to find out if the new composition has rejuvenating effects on rodents. It is worth noting that mice weigh about 10% of rats, so the amount of the composition to be produced is much smaller, which means it can be made more quickly.

The experiment with mice will involve only old mice: one group of 9 treated mice and one group of 9 control mice. We will test grip strength, memory, and blood markers. Thus, within a few weeks after the injections in the mice, we will be able to determine if there is any increase in grip strength. Three months after the first dose, the mice will receive a second dose. This time, we will begin the experiment when the mice are middle-aged (12 months old) and conclude it when they are elderly (17 months old). This will ensure that a significant number of mice, including the controls, remain alive after the 5-month experiment.

4 Likes